Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer,Cancer Cell

当前位置： X-MOL 学术 › Cancer Cell › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
Cancer Cell ( IF 48.8 ) Pub Date : 2022-04-20 , DOI: 10.1016/j.ccell.2022.04.012
Philip C Mack ₁ , Jorge E Gomez ₁ , Ananda M Rodilla ₁ , Juan Manuel Carreño ₂ , Chih-Yuan Hsu ₃ , Christian Rolfo ₁ , Noy Meshulami ₁ , Amy Moore ₄ , Rachel I Brody ₅ , Jennifer C King ₆ , Jacquelyn Treatman ₁ , Sooyun Lee ₁ , Ariel Raskin ₂ , Komal Srivastava ₂ , Charles R Gleason ₂ , Diego de Miguel-Perez ₁ , ₇ , Johnstone Tcheou ₂ , Dominika Bielak ₂ , Rashmi Acharya ₆ , David E Gerber ₈ , Nicholas Rohs ₁ , Claudia I Henschke ₉ , David F Yankelevitz ₉ , Viviana Simon ₁₀ , John D Minna ₈ , Paul A Bunn ₁₁ , Adolfo García-Sastre ₁₂ , Florian Krammer ₁₃ , Yu Shyr ₃ , Fred R Hirsch ₁₄

Affiliation

Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Biostatistics, Vanderbilt University, Nashville, TN, USA.
LUNGevity Foundation, Bethesda, MD, USA.
Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
GO2 Foundation for Lung Cancer, Washington, DC, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Hamon Center for Therapeutic Oncology Research, Departments of Internal Medicine and Pharmacology UT Southwestern Medical Center, Dallas, TX, USA.
Diagnostic, Molecular and Interventional Radiology, Mount Sinai Health System, New York, NY, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Internal Medicine, University of Colorado Cancer Center, Denver, CO, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Center for Thoracic Oncology, Tisch Cancer Institute and Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.